4//SEC Filing
ACADIA PHARMACEUTICALS INC 4
Accession 0001415889-17-000308
$ACADCIK 0001070494operating
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 6:01 PM ET
Size
8.6 KB
Accession
0001415889-17-000308
Insider Transaction Report
Form 4
Moore Terrence O
EVP, CHIEF COMMERCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2017-02-21$34.45/sh+7,856$270,639→ 9,527 total - Exercise/Conversion
Stock Option (right to buy)
2017-02-21−7,856→ 82,500 totalExercise: $34.45Exp: 2025-03-19→ Common Stock (7,856 underlying) - Sale
Common Stock
2017-02-21$39.65/sh−7,856$311,490→ 1,671 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2015, as amended in June 2016. All sales under the trading plan have been completed.
- [F2]25% of the shares subject to the Stock Option vested and became exercisable on March 20, 2016. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070494
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 6:01 PM ET
- Size
- 8.6 KB